Results 191 to 200 of about 284,481 (355)
Targeting Ovarian Neoplasms: Subtypes and Therapeutic Options. [PDF]
Hong SY, Cho A, Chae CS, You HJ.
europepmc +1 more source
Understanding the Value of Tumor Markers in Pediatric Ovarian Neoplasms. [PDF]
Lawrence AE +29 more
europepmc +1 more source
In this manuscript, protein disulfide isomerase A3 (PDIA3) is identified as a key factor mediating the susceptibility of ferroptosis in GBM. Inhibition of PDIA3 enhances IKE or cystine starvation‐induced ferroptosis in GBM cells by resulting in the accumulation of lipid peroxidation and a reduction in GSH level.
Jie Zhang +19 more
wiley +1 more source
HiST, a multiscale deep learning framework, reconstructs spatially resolved gene expression profiles directly from histological images. It accurately identifies tumor regions, captures intratumoral heterogeneity, and predicts patient prognosis and immunotherapy response.
Wei Li +8 more
wiley +1 more source
Staging discordance in apparent early-stage ovarian neoplasms: prevalence, prognosis, and practical risk stratification. [PDF]
Abdelaziz MAM +6 more
europepmc +1 more source
A20 Facilitates Oxaliplatin Sensitivity in Colorectal Cancer Through Monoubiquitylation of IKK‐β
This study demonstrates that the expression of A20, a ubiquitin‐editing enzyme, is positively correlated with oxaliplatin sensitivity in colorectal cancer (CRC). Mechanistically, A20 enhances oxaliplatin sensitivity by inhibiting NF‐κB nuclear translocation through monoubiquitination of IKK‐β.
Fan Luo +12 more
wiley +1 more source
NAC1/ACOX2 Axis as a Novel Therapeutic Target for Endometriosis-Related Ovarian Neoplasms. [PDF]
Sonia SB +10 more
europepmc +1 more source
Constitutive expression of progesterone receptor isoforms promotes the development of hormone-dependent ovarian neoplasms. [PDF]
Wetendorf M +11 more
europepmc +1 more source

